Experts in neurology share considerations for the management of ethnically diverse and underrepresented populations including those of reproductive age who have the Epstein-Barr virus.
EP. 1: Viruses and the Immune System
Lawrence Steinman, MD, provides an overview of the role viruses play in the activation of the immune system, highlighting their role in triggering neuroinflammatory conditions.
EP. 2: The Impact of Viruses on the Immune System
Scott Newsome, DO, and Lawrence Steinman, MD, discuss the pathophysiology of the interactions between viruses and the immune system and explore how this can lead to autoimmune diseases.
EP. 3: The Role of Epstein-Barr Virus in Autoimmune Diseases
Amit Bar-Or, MD, FRCPC, and Bridget A. Bagert, MD, share their opinions on the role the Epstein-Barr virus plays in the development of multiple sclerosis, highlighting recent publications examining this link.
EP. 4: The Role of Viruses in the Development of Multiple Sclerosis
Ahmed Obeidat, MD, PhD, comments on other viruses that have been linked to the development of multiple sclerosis and discusses how they can be both protective and detrimental.
EP. 5: Investigations Into the Causal Link Between EBV and MS
Lawrence Steinman, MD, discusses his recent publication, which demonstrated the causal link between Epstein-Barr virus and multiple sclerosis, highlighting key findings and conclusions.
EP. 6: Clinical Implications and Patient Education Surrounding the Link Between Epstein-Barr Virus and Multiple Sclerosis
Bridget A. Bagert, MD, and Ahmed Obeidat, MD, PhD, examine the clinical implications of a causal link between Epstein-Barr virus and multiple sclerosis and provide insight on how to discuss this link with patients.
EP. 7: Screening and Diagnostic Considerations for MS
Experts in neurology discuss screening and diagnostic considerations for a patient newly diagnosed with multiple sclerosis.
EP. 8: Targeted Vaccination for the Prevention of EBV
Amit Bar-Or, MD, FRCPC, discusses the potential impact vaccination against Epstein-Barr virus could play on multiple sclerosis rates, highlighting recent investigations.
EP. 9: Considering Vaccination for Various MS Patient Populations
Bridget A. Bagert, MD, leads a discussion on the ideal patient populations for using a potential vaccine for multiple sclerosis, and the panel comments on other factors to consider when administering vaccines.
EP. 10: Clinical Trial Design Considerations for MS
Experts in neurology comment on clinical trial design considerations and discuss novel imaging techniques and biomarkers that they consider most important to investigate for multiple sclerosis.
EP. 11: Hidden Symptoms of Multiple Sclerosis
Doctors in neurology comment on the hidden symptoms of multiple sclerosis and debate whether they should be treatment targets.
EP. 12: Moving From the Bench to the Bedside in MS Management
Amit Bar-Or, MD, FRCPC, and Bridget A. Bagert, MD, share their opinions on how to move investigative treatments for multiple sclerosis off the laboratory bench and into clinical practice.
EP. 13: Novel and Emerging Targets in Multiple Sclerosis
Experts in neurology share their hopes for the future of multiple sclerosis treatment and discuss unmet needs and novel targets.
2 Clarke Drive Cranbury, NJ 08512